cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.4553102
title: OA Diamond Journals Study. Dataset

description: <strong>Context</strong><br> From June 2020 to February 2021, a consortium of 10 organisations undertook a large-scale study on open access journals across the world that are free for readers and authors, usually referred to as “OA diamond journals”. This study was commissioned by cOAlition S in order to gain a better understanding of the OA diamond landscape. <strong>Presentation</strong><br> The study undertook a statistical analysis of several bibliographic databases, surveyed 1,619 journals, collected 7,019 free text submissions and other data from 94 questions, and organised three focus groups with 11 journals and 10 interviews with hosting platforms. It collected 163 references in the academic literature, and inventoried 1048 journals not listed in DOAJ. The results of the study are available in the following outputs: Findings Report - DOI: 10.5281/zenodo.4558704 Recommendations Report- DOI:10.5281/zenodo.4562790 References Library - DOI: 10.5281/zenodo.4562816 Journals Inventory - DOI: 10.5281/zenodo.4562828 Dataset - DOI: 10.5281/zenodo.4553103 This dataset contains data used by and partly generated by the OA Diamond Journals Study on open access journals that do not charge authors. It contains the data files themselves as well as some readme texts with variable lists. <strong>Available files:</strong> Survey questionnaire, English version (PDF) Survey data without identifying information and without free texts answers (as these might also include identifying information) (CSV). This includes, for some questions, data from DOAJ for journals present in that database. Readme text with the variable list for the survey data file (TXT) Stratified sample of 500 records from the ROAD database of open access journals downloaded 20201102 (CSV) Readme text with the variable list for the ROAD database sample (TXT) Directory of Open Access Journals (DOAJ) metadata downloaded 20200602 (CSV) Directory of Open Access Journals (DOAJ) metadata downloaded 20200918 (CSV) Added and Removed change log DOAJ, downloaded 20210121 (CSV) Readme text with variable list for the Added and Removed change log DOAJ (TXT) All data are available for reuse under a CC0 license. Additionally, an online version of the survey results (excluding DOAJ data and excluding free text answers) is available from SurveyMonkey
DOI: 10.5281/zenodo.4562816
title: OA Diamond Journals Study. References Library

description: <strong>Context</strong><br> From June 2020 to February 2021, a consortium of 10 organisations undertook a large-scale study on open access journals across the world that are free for readers and authors, usually referred to as “OA diamond journals”. This study was commissioned by cOAlition S in order to gain a better understanding of the OA diamond landscape. <strong>Presentation</strong><br> The study undertook a statistical analysis of several bibliographic databases, surveyed 1,619 journals, collected 7,019 free text submissions and other data from 94 questions, and organised three focus groups with 11 journals and 10 interviews with hosting platforms. It collected 163 references in the academic literature, and inventoried 1048 journals not listed in DOAJ. The results of the study are available in the following outputs: Findings Report - DOI: 10.5281/zenodo.4558704 Recommendations Report- DOI:10.5281/zenodo.4562790 References Library - DOI: 10.5281/zenodo.4562816 Journals Inventory - DOI: 10.5281/zenodo.4562828 Dataset - DOI: 10.5281/zenodo.4553103 <strong>Zotero Library</strong> We conducted a literature search, which led us to collect 163 references, focusing more particularly on the open access business models. The literature review was used primarily to design the survey, prepare the focus groups, and analyse the answers collected. The references are stored in a Zotero library, available online.<br>
DOI: 10.5281/zenodo.4562815
title: OA Diamond Journals Study. References Library

description: <strong>Context</strong><br> From June 2020 to February 2021, a consortium of 10 organisations undertook a large-scale study on open access journals across the world that are free for readers and authors, usually referred to as “OA diamond journals”. This study was commissioned by cOAlition S in order to gain a better understanding of the OA diamond landscape. <strong>Presentation</strong><br> The study undertook a statistical analysis of several bibliographic databases, surveyed 1,619 journals, collected 7,019 free text submissions and other data from 94 questions, and organised three focus groups with 11 journals and 10 interviews with hosting platforms. It collected 163 references in the academic literature, and inventoried 1048 journals not listed in DOAJ. The results of the study are available in the following outputs: Findings Report - DOI: 10.5281/zenodo.4558704 Recommendations Report- DOI:10.5281/zenodo.4562790 References Library - DOI: 10.5281/zenodo.4562816 Journals Inventory - DOI: 10.5281/zenodo.4562828 Dataset - DOI: 10.5281/zenodo.4553103 <strong>Zotero Library</strong> We conducted a literature search, which led us to collect 163 references, focusing more particularly on the open access business models. The literature review was used primarily to design the survey, prepare the focus groups, and analyse the answers collected. The references are stored in a Zotero library, available online.<br>
DOI: 10.6084/m9.figshare.14215874
title: Supplementary Material for: Additional Value of Preoperative Albumin for Surgical Risk Stratification among Colorectal Cancer Patients

description: <b><i>Background:</i></b> BMI ≤18.5 kg/m<sup>2</sup> and preoperative weight loss may lead to inaccurate assessment of nutritional status, given the increasing prevalence of obesity. The aim of this study was to assess whether clinical evaluation of malnutrition based on these parameters is sufficient to predict complications after colorectal cancer surgery. <b><i>Materials and Methods:</i></b> The American College of Surgeons-National Quality Improvement Program database was queried from 2005 to 2018. Patients undergoing elective colorectal cancer surgery were divided into 4 groups: (1) albumin &lt;3.1 g/dL within 21 days of surgery, (2) European Society for Clinical Nutrition and Metabolism (ESPEN) 2 clinical parameters for malnutrition (≥10% loss of weight/6 months <i>plus</i> [BMI &lt;20 kg/m<sup>2</sup> if age &lt;70 years OR BMI &lt;22 kg/m<sup>2</sup> if age ≥70 years]), (3) both aforementioned criteria, and (4) none of aforementioned criteria. <b><i>Results:</i></b> Of 82,280 patients, 5,932 (7.2%) had hypoalbuminemia &lt;3.1 g/dL, 764 (0.9%) fulfilled clinical ESPEN 2 parameters, and 338 (0.4%) met both criteria. After adjusting for baseline confounders, patients in the hypoalbuminemia group had a higher risk of overall complications (odds ratio [OR] 1.92, <i>p</i> &lt; 0.05 vs. OR 1.18 in the ESPEN 2 group, <i>p</i> &lt; 0.05), major complications (OR 1.98, <i>p</i> &lt; 0.05 vs. OR 1.20, <i>p</i> &lt; 0.05), surgical complications (OR 1.77, 95% <i>p</i> &lt; 0.05 vs. OR 1.1, <i>p</i> &gt; 0.05), medical complications (OR 1.73, <i>p</i> &lt; 0.05 vs. OR 1.16, <i>p</i> &gt; 0.05), surgical site infection (OR 1.32, <i>p</i> &lt; 0.05 vs. OR 0.86, <i>p</i> &gt; 0.05), and prolonged hospitalization (OR 1.79, <i>p</i> &lt; 0.05 vs. OR 1.22, <i>p</i> &lt; 0.05). Patients who met both criteria were at highest risk. <b><i>Conclusions:</i></b> Preoperative measurement of serum albumin appears to be essential to identify patients at risk for complications after colorectal cancer surgery. Clinical evaluation through BMI and weight loss alone may underestimate surgery-associated risks in the USA.
DOI: 10.5281/zenodo.4593056
title: Water restriction in viviparous lizards causes transgenerational effects on behavioral anxiety and immediate effects on exploration behavior

description: Raw data of the article "Water restriction in viviparous lizards causes transgenerational effects on behavioral anxiety and immediate effects on exploration behavior" by Rozen-Rechels D. et al., published in Behavioral Ecology and Socioiology 93, 23 in 2018 (https://doi.org/10.1007/s00265-018-2443-4). These data are freely available in csv format. See the readme file for metadata explanation. Data were formatted by the first author David Rozen-Rechels and collected according to standards and procedures described in the companion journal article.
description: Funding: Centre National de la Recherche Scientifique (CNRS) and Agence Nationale de la Recherche grant (ANR-13-JSV7-0011-01)
DOI: 10.5519/qd.0fnke7tf
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (3194 records)
DOI: 10.6084/m9.figshare.14215958
title: Supplementary Material for: First Experiences with Alpelisib in Clinical Routine: Case Reports from a German Breast Center

description: <b><i>Introduction:</i></b> The phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib is the only approved agent for treating ­<i>PIK3CA</i>-mutated, hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC). Trials have reported hyperglycemia, diarrhea, and rash as the main grade 3 side effects. <b><i>Methods:</i></b> In a managed access program (ClinicalTrials.gov ID: NCT03706573; start: 06/2019), 8 HR+ HER2– ABC patients with a median 4.5 prior therapy lines were treated with alpelisib at the Breast Center of the Ludwig-Maximilian University (LMU) Hospital, Munich, based on the results of a new-generation sequencing (NGS) panel and <i>PIK3CA</i> mutation analysis by the Molecular Tumor Board of the Comprehensive Cancer Center, Munich. <b><i>Results:</i></b> Median therapy duration was 3.42 months for patients who discontinued and 3.95 months for those still on alpelisib (4 pts). Five had hyperglycemia (1 with grade 3) with fasting glucose levels of up to 450 mg/dL that required hospitalization and insulin therapy. Two experienced rash (grades 1 and 3) and 2 reported grade 3 diarrhea. Supportive therapy as well as interruption and/or dose reduction were necessary to control treatment-associated side effects. <b><i>Conclusion:</i></b> Patient education and a well-trained, interdisciplinary team including diabetologists, from the initiation of alpelisib treatment onwards, are essential to safely treat ABC patients with this new drug and to maintain their quality of life and ensure their survival.
DOI: 10.6084/m9.figshare.14215958.v1
title: Supplementary Material for: First Experiences with Alpelisib in Clinical Routine: Case Reports from a German Breast Center

description: <b><i>Introduction:</i></b> The phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib is the only approved agent for treating ­<i>PIK3CA</i>-mutated, hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC). Trials have reported hyperglycemia, diarrhea, and rash as the main grade 3 side effects. <b><i>Methods:</i></b> In a managed access program (ClinicalTrials.gov ID: NCT03706573; start: 06/2019), 8 HR+ HER2– ABC patients with a median 4.5 prior therapy lines were treated with alpelisib at the Breast Center of the Ludwig-Maximilian University (LMU) Hospital, Munich, based on the results of a new-generation sequencing (NGS) panel and <i>PIK3CA</i> mutation analysis by the Molecular Tumor Board of the Comprehensive Cancer Center, Munich. <b><i>Results:</i></b> Median therapy duration was 3.42 months for patients who discontinued and 3.95 months for those still on alpelisib (4 pts). Five had hyperglycemia (1 with grade 3) with fasting glucose levels of up to 450 mg/dL that required hospitalization and insulin therapy. Two experienced rash (grades 1 and 3) and 2 reported grade 3 diarrhea. Supportive therapy as well as interruption and/or dose reduction were necessary to control treatment-associated side effects. <b><i>Conclusion:</i></b> Patient education and a well-trained, interdisciplinary team including diabetologists, from the initiation of alpelisib treatment onwards, are essential to safely treat ABC patients with this new drug and to maintain their quality of life and ensure their survival.
DOI: 10.21227/n9wg-3w65
title: MCData

description: The MCData was designed and produced for mouthcavity detection and segmentation. This dataset can be utilized for training and testing of mouth cavity instancesegmentation networks. This dataset is the first availabledataset for detecting and segmentation of mouth cavity maincomponents to the best of the authors’ knowledge.
DOI: 10.5517/ccdc.csd.cc21pnyc
title: CCDC 1897663: Experimental Crystal Structure Determination

description: Related Article: Ökten Üngör, Hoa Phan, Eun Sang Choi, Judith K. Roth, Michael Shatruk|2019|J.Magn.Magn.Mater.|497|165984|doi:10.1016/j.jmmm.2019.165984
DOI: 10.5517/ccdc.csd.cc23ykd1
title: CCDC 1964823: Experimental Crystal Structure Determination

description: Related Article: Wen-Huan Huang, Qiao-Hong Li, Dan-Yang Yu, Yu-Huan Tang, Duo-Yu Lin, Fei Wang, Jian Zhang|2021|Inorg.Chem.|60|3074|doi:10.1021/acs.inorgchem.0c03359
DOI: 10.5517/ccdc.csd.cc23ykf2
title: CCDC 1964824: Experimental Crystal Structure Determination

description: Related Article: Wen-Huan Huang, Qiao-Hong Li, Dan-Yang Yu, Yu-Huan Tang, Duo-Yu Lin, Fei Wang, Jian Zhang|2021|Inorg.Chem.|60|3074|doi:10.1021/acs.inorgchem.0c03359
DOI: 10.5517/ccdc.csd.cc23ykh4
title: CCDC 1964826: Experimental Crystal Structure Determination

description: Related Article: Wen-Huan Huang, Qiao-Hong Li, Dan-Yang Yu, Yu-Huan Tang, Duo-Yu Lin, Fei Wang, Jian Zhang|2021|Inorg.Chem.|60|3074|doi:10.1021/acs.inorgchem.0c03359
DOI: 10.5517/ccdc.csd.cc25s0yy
title: CCDC 2019090: Experimental Crystal Structure Determination

description: Related Article: Baihua Chen, Bijun Liu, Yao He, Daibing Luo, Wanjun Mu, Yuchuan Yang, Yanqiu Yang, Shuming Peng, Xingliang Li|2021|Inorg.Chem.|60|3139|doi:10.1021/acs.inorgchem.0c03480
DOI: 10.5517/ccdc.csd.cc13cmsw
title: CCDC 1024078: Experimental Crystal Structure Determination

description: Related Article: Avik De, Olivia Basu, Tannistha Basu, Raju Mondal|2021|Cryst.Growth Des.|21|1461|doi:10.1021/acs.cgd.0c01042
DOI: 10.5517/ccdc.csd.ccr4pvd
title: CCDC 689714: Experimental Crystal Structure Determination

description: Related Article: Avik De, Olivia Basu, Tannistha Basu, Raju Mondal|2021|Cryst.Growth Des.|21|1461|doi:10.1021/acs.cgd.0c01042
DOI: 10.5517/ccdc.csd.cc25ztdd
title: CCDC 2025614: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.5517/ccdc.csd.cc25ztff
title: CCDC 2025615: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.5517/ccdc.csd.cc25ztgg
title: CCDC 2025616: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.5517/ccdc.csd.cc25zthh
title: CCDC 2025617: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.5517/ccdc.csd.cc25ztjj
title: CCDC 2025618: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.5517/ccdc.csd.cc25ztkk
title: CCDC 2025619: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.5517/ccdc.csd.cc25ztll
title: CCDC 2025620: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.5517/ccdc.csd.cc25ztmm
title: CCDC 2025621: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.5517/ccdc.csd.cc25ztnn
title: CCDC 2025622: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.5517/ccdc.csd.cc25ztpp
title: CCDC 2025623: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.5517/ccdc.csd.cc25ztqq
title: CCDC 2025624: Experimental Crystal Structure Determination

description: Related Article: Qixuan Zheng, Daniel K. Unruh, Kristin M. Hutchins|2021|Cryst.Growth Des.|21|1507|doi:10.1021/acs.cgd.0c01197
DOI: 10.26302/sshade/experiment_sb_20210218_001
title: Optical constants of glassy SiS$_2$ in MIR/FIR
DOI: 10.5281/zenodo.4593074
title: A relational understanding of farm businesses as coupled social-ecological systems

description: Using the case of the Echigo-Tsumari Art Triennale (ETAT) in Japan, this research project examines how Japanese alternative farmers use art to make sense of their farming practices, and to relate to rural spaces. These alternative farmers make active and intentional efforts to farm differently: they strive to maintain traditional practices and thus landscapes, and they establish their own marketing channels, and develop direct relationship with consumers. Qualitative interviews and focus group discussions were conducted with alternative farmers. Using pictures of the artworks of the ETAT, they were asked how they relate the artworks to their farming practices, values and approaches. The purpose of the study was to (1) collect evidence on the context and relations between art and the farming of alternative farmers; (2) explore the perspective of farmers about the impact of art and opportunities of art festivals on their farming practices; (3) develop recommendations to inform the use of art to promote diversity in farming practices and thus resilience of farms and rural communities.
DOI: 10.6084/m9.figshare.14214560
title: Open data.xlsx

description: Nodes and Edges data
DOI: 10.6084/m9.figshare.14214560.v1
title: Open data.xlsx

description: Nodes and Edges data
DOI: 10.15129/6e0c2a04-35bc-4d45-b623-c72db9d94f2d
title: Communication data for a 750 m optical link using a micro-LED and single photon avalanche diode array

description: This dataset contains a .mat (MATLAB) file and a .txt readme with details about the variables contained. The dataset is for experimental work using a single micro-LED and a single-photon avalanche diode array for optical communications over a distance of 750 m. This dataset supports the findings of "High-sensitivity inter-satellite optical communications using low size, weight and power hardware"
DOI: 10.6084/m9.figshare.14216036
title: Supplementary Material for: Long-Term Remission with Ipilimumab/Nivolumab in Two Patients with Different Soft Tissue Sarcoma Subtypes and No PD-L1 Expression

description: Checkpoint inhibitor therapy has been shown to improve outcomes in multiple solid malignancies; however, data are limited in soft tissue sarcoma. We present two cases of patients with advanced soft tissue sarcoma of different subtypes (dedifferentiated liposarcoma and myxofibrosarcoma) with zero percent PD-L1 expression by immunohistochemistry who were treated with ipilimumab and nivolumab followed by maintenance nivolumab. Both patients had failed multiple lines of systemic treatment and experienced long-term remission after starting ipilimumab and nivolumab. Genetic testing revealed that no genetic mutations were found in common between the two cases. One patient received concurrent cryoablation, which may have sensitized his tumor to immunotherapy. Checkpoint inhibitor therapy may improve outcomes in soft tissue sarcoma regardless of PD-L1 status, especially when combined with cryoablation. Studies are needed to evaluate whether treatment response varies by sarcoma subtype and what molecular markers can be used to guide patient selection.
DOI: 10.6084/m9.figshare.14216036.v1
title: Supplementary Material for: Long-Term Remission with Ipilimumab/Nivolumab in Two Patients with Different Soft Tissue Sarcoma Subtypes and No PD-L1 Expression

description: Checkpoint inhibitor therapy has been shown to improve outcomes in multiple solid malignancies; however, data are limited in soft tissue sarcoma. We present two cases of patients with advanced soft tissue sarcoma of different subtypes (dedifferentiated liposarcoma and myxofibrosarcoma) with zero percent PD-L1 expression by immunohistochemistry who were treated with ipilimumab and nivolumab followed by maintenance nivolumab. Both patients had failed multiple lines of systemic treatment and experienced long-term remission after starting ipilimumab and nivolumab. Genetic testing revealed that no genetic mutations were found in common between the two cases. One patient received concurrent cryoablation, which may have sensitized his tumor to immunotherapy. Checkpoint inhibitor therapy may improve outcomes in soft tissue sarcoma regardless of PD-L1 status, especially when combined with cryoablation. Studies are needed to evaluate whether treatment response varies by sarcoma subtype and what molecular markers can be used to guide patient selection.
DOI: 10.6084/m9.figshare.14176574.v3
title: An integrated gene catalog and over 10,000 metagenome-assembled genomes from the gastrointestinal microbiome of ruminants

description: All MAGs and USGs including genome and ORF prediction have been deposited in here.
DOI: 10.5281/zenodo.4604584
title: Trialstreamer data

description: Trialstreamer annotated collection of RCTs. This respository contains baseline files (large), and subsequent updates (daily for PubMed, weekly for ICTRP).
DOI: 10.5281/zenodo.4604575
title: Concentration-Dependent Self-Assembly of an Unusually Large Hexameric Hydrogen-Bonded Molecular Cage

description: Data underlying the figures in the publication "Concentration-Dependent Self-Assembly of an Unusually Large<br> Hexameric Hydrogen-Bonded Molecular Cage"; <em>Chem. Eur.J.</em>, <strong>2021</strong>, 27,4447 –4453. Table of contents: 1. Figure 1 1.1 ChemDraw File 1.2 Spantan Models 2. Figure 2 2.1 ChemDraw File 2.2 X-Ray Data 3. Figure 3 3.1 ChemDraw File 3.2 NMR Spectra; comparison 4. Figure 4 4.1 Figure 4a. ChemDraw File 4.2 Figure 4b. Partial NMR Spectra; comparison 4.3 Figure 4c. Excel File 4.4 Figure 4d. DOSY NMR Spectrum 5. Figure 5 5.1 Figure 5a. ChemDraw File 5.2 Figure 5b. Excel file; concentration dependence 5.3 Figure 5c. Excel file; comparison of the diffusion coefficients
DOI: 10.5281/zenodo.4604574
title: Concentration-Dependent Self-Assembly of an Unusually Large Hexameric Hydrogen-Bonded Molecular Cage

description: Data underlying the figures in the publication "Concentration-Dependent Self-Assembly of an Unusually Large<br> Hexameric Hydrogen-Bonded Molecular Cage"; <em>Chem. Eur.J.</em>, <strong>2021</strong>, 27,4447 –4453. Table of contents: 1. Figure 1 1.1 ChemDraw File 1.2 Spantan Models 2. Figure 2 2.1 ChemDraw File 2.2 X-Ray Data 3. Figure 3 3.1 ChemDraw File 3.2 NMR Spectra; comparison 4. Figure 4 4.1 Figure 4a. ChemDraw File 4.2 Figure 4b. Partial NMR Spectra; comparison 4.3 Figure 4c. Excel File 4.4 Figure 4d. DOSY NMR Spectrum 5. Figure 5 5.1 Figure 5a. ChemDraw File 5.2 Figure 5b. Excel file; concentration dependence 5.3 Figure 5c. Excel file; comparison of the diffusion coefficients